SynthesisNature communications2019

Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.

Stefano Annunziato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.